CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,353,474
- in 27 filings, $104.4M under 10b5-1 plans
Net −$104,353,474. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.4M Director sold 14% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-02 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −317 | $400.29 | $127K | 46,249 |
| 2026-11-02 | Sheena Jonathan Director | Sale 10b5-1 | −3 | $388.20 | $1K | 217,683 |
| 2026-11-02 | Sheena Jonathan Director | Sale 10b5-1 | −109 | $400.29 | $44K | 217,574 |
| 2026-11-02 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale 10b5-1 | −17 | $388.20 | $7K | 2,117,659 |
| 2026-11-02 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale 10b5-1 | −731 | $400.29 | $293K | 2,116,928 |
| 2026-10-30 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,906 | $425.55 | $811K | 46,574 |
| 2026-10-28 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −313 | $425.32 | $133K | 49,345 |
| 2026-10-28 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −865 | $426.87 | $369K | 48,480 |
| 2026-10-28 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Sale 10b5-1 | −898 | $426.34 | $383K | 195,578 |
| 2026-10-28 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −1,162 | $426.34 | $495K | 104,742 |
| 2026-10-28 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −968 | $426.34 | $413K | 168,221 |
| 2026-10-28 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −3,430 | $426.34 | $1.5M | 91,232 |
| 2026-10-28 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,198 | $426.34 | $511K | 49,658 |
| 2026-10-28 | Sheena Jonathan Director | Sale 10b5-1 | −187 | $426.34 | $80K | 217,686 |
| 2026-10-27 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Sale 10b5-1 | −781 | $406.00 | $317K | 196,476 |
| 2026-10-27 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −1,010 | $406.00 | $410K | 105,904 |
| 2026-10-27 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −884 | $406.00 | $359K | 169,189 |
| 2026-10-27 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −2,264 | $406.00 | $919K | 94,662 |
| 2026-10-27 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −781 | $406.00 | $317K | 50,856 |
| 2026-10-27 | Sheena Jonathan Director | Sale 10b5-1 | −291 | $406.00 | $118K | 217,873 |
Page 3 of 38 · 753 trades